as 05-30-2025 4:00pm EST
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | IRVINE |
Market Cap: | 8.2B | IPO Year: | 2007 |
Target Price: | $187.00 | AVG Volume (30 days): | 770.5K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -9.23 | EPS Growth: | N/A |
52 Week Low/High: | $101.61 - $194.88 | Next Earning Date: | 05-06-2025 |
Revenue: | $2,126,800,000 | Revenue Growth: | 16.68% |
Revenue Growth (this year): | -25.99% | Revenue Growth (next year): | 7.74% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Muhsin Bilal | MASI | Chief Operating Officer | May 12 '25 | Sell | $163.73 | 10,000 | $1,632,781.24 | 24,172 | |
REYNOLDS CRAIG B | MASI | Director | Mar 14 '25 | Sell | $166.13 | 2,053 | $341,067.97 | 16,581 | |
Muhsin Bilal | MASI | Chief Operating Officer | Mar 10 '25 | Sell | $167.65 | 30,000 | $5,024,585.10 | 24,172 |
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
Cybersecurity Dive
4 days ago
Business Wire
4 days ago
StockStory
12 days ago
StockStory
17 days ago
MT Newswires
17 days ago
Argus Research
18 days ago
Insider Monkey
22 days ago
Zacks
23 days ago
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.